Nidan Laboratories & Healthcare Ltd Share Price

Healthcare

NSE: NIDAN Small Cap ISIN: INE0J6L01013

As on 19 November 2025 at 01:30 IST

Stock Not Traded in NSE

Over 1 Month

9.46%

Over 6 Months

1.25%

Over 1 Year

-30.17%

Over 3 Years

-64.97%

Nidan Laboratories & Healthcare Ltd Summary

Close ₹20.25

Open ₹20.15

High ₹20.75

Low ₹20.15

Volume 5,000

Net Turnover (in Cr) ₹0.01

52Wk High -

52Wk Low -

52Wk High / Low

Nidan Laboratories & Healthcare Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹28.15

EPS (TTM) 1.41

Book Value (BV) 49.05

Div. Yield -

P/E (TTM) 14.26

Price/Book Value 0.41

Delivery % 60 %

Face Value 10

Key Ratios

PE Ratio 11.65

PB Ratio 0.34

EV to Sales 1.31

PEG Ratio -0.07

ROA 2.48

ROE 2.95

Debt-Equity 0.18

Net Profit Margin 8.07

Operating Profit Margin 29.80

Nidan Laboratories & Healthcare Ltd Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

No data available

Balance Sheet

No data available

Cash Flow

No data available

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	26.78	26.92	27.60	30.06	21.44
Total Expenses	24.02	22.78	22.78	25.54	18.14
Profit Before Tax	2.76	-2.37	4.81	4.52	3.30
Profit After Tax	1.98	-3.23	3.54	2.66	2.30
Operating Profit After Depreciation	4.90	6.32	7.03	7.19	6.76

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	16.33	17.95	21.39	20.46	19.92
Total Non Current Assets	71.74	52.27	63.52	63.18	30.82
Total Current Assets	11.20	30.28	20.88	25.30	22.92
Total Assets	82.94	82.55	84.40	88.48	53.74
Total Shareholder's Fund	68.18	66.21	69.44	65.90	13.33

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	2.28	5.52	10.97	7.83	4.35
Net Cash Used In Investing Activities	-0.22	-10.60	-0.29	-35.74	-3.22
Net Cash Used In Financing Activities	-3.01	-0.49	-10.37	28.72	-1.22

No data available

Particulars (in ₹ Cr.)	2021-09	2021-06
Total Revenue	16.52	7.83
Total Expenses	10.73	4.67
Profit Before Tax	2.32	1.39
Profit After Tax	1.80	1.09
Operating Profit after Depreciation	5.80	3.17

Nidan Laboratories & Healthcare Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 20.02

S2 19.78

S3 19.42

Pivot 20.38

R1 20.62

R2 20.98

R3 21.22

Moving Average

20 SMA 19.42

50 SMA 18.91

100 SMA 19.50

200 SMA 20.58

Nidan Laboratories & Healthcare Ltd Corporate Actions

No available data

AGM Date: 28 Sep 2022

Nidan Laboratories And Healthcare Limited has informed the Exchange about Notice of Annual General Meeting to be held on 28-Sep-2022 Nidan Laboratories And Healthcare Limited has informed the Exchange that Register of Members & Share Transfer Books of the Company will remain closed from 21-Sep-2022 to 28-Sep-2022 for the purpose of Meeting. (As Per NSE Announcement Dated on 05.09.2022) Nidan Laboratories And Healthcare Limited has informed the Exchange about Proceedings of Annual General Meeting held on 28-Sep-2022 (As Per NSE Announcement Dated on 28.09.2022) Nidan Laboratories And Healthcare Limited has informed the Exchange about Voting results and Scrutinizer report of Annual General Meeting held on 28-Sep-2022 (As Per NSE Announcement Dated on 30.09.2022)

AGM Date: 27 Sep 2023

Nidan Laboratories And Healthcare Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 27, 2023 Nidan Laboratories And Healthcare Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 27, 2023 (As Per NSE Announcement Dated on: 27/09/2023)

AGM Date: 27 Sep 2024

Nidan Laboratories And Healthcare Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 27, 2024 Nidan Laboratories And Healthcare Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 27, 2024 (As Per NSE Announcement Dated on: 27/09/2024) Nidan Laboratories And Healthcare Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 27, 2024. Further, the company has informed the Exchange regarding voting results. (As Per NSE Announcement Dated on: 28/09/2024)

AGM Date: 02 Sep 2025

The 25th Annual General Meeting of the Company is scheduled to be held on Tuesday, September 02nd, 2025 at 11.30 a.m. (IST) through Video Conferencing (VC) / Other Audio Visual Means (OAVM) facility, in compliance with the provisionsof the Companies Act, 2013 (the Act) and Rules thereof as amended, read with general circulars numbered 14/2020, 17/2020, 20/2020, 02/2021, 21/2021, 02/2022, 10/2022, and 09/2023 dated April 8, 2020, April 13, 2020, May 5, 2020, January 13, 2021, December 14, 2021, May 5, 2022, December 28, 2022, Pursuant to the provisions of the Companies Act, 2013 and Regulation 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Register of Members and Share Transfer Books of the Company will remain closed from Wednesday, 27th August, 2025 to, Tuesday, 2nd September, 2025 (both days inclusive) for the purpose of 25thAGM to be held on Tuesday, September 02nd, 2025.The Cut-off date has been fixed as Tuesday, August 26, 2025 for determining the eligibility of the Members to vote by remote e-voting or by e-voting at 25th AGMThe remote e-voting shall commence on Saturday, August 30, 2025 at 9.00 a.m. (IST) and ends on Monday, September 01st, 2025 at 5.00 p.m. (IST) Nidan Laboratories And Healthcare Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 02, 2025 (As per NSE Announcement dated on: 03.09.2025) Nidan Laboratories And Healthcare Limited has informed the Exchange about Shareholders meeting (As Per NSE Announcement Dated On : 02.09.2025)

Nidan Laboratories & Healthcare Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
Max Healthcare Institute Ltd	₹1,121.90	₹1,09,099.45
Apollo Hospitals Enterprise Ltd	₹7,488.40	₹1,07,671.70
Fortis Healthcare Ltd	₹944.15	₹71,279.37
Narayana Hrudayalaya Ltd	₹2,027.90	₹41,442.33
Aster DM Healthcare Ltd	₹678.35	₹35,146.74

Nidan Laboratories & Healthcare Ltd Top Mutal Funds Invested

No data available

Nidan Laboratories & Healthcare Ltd News

Nidan Laboratories & Healthcare to convene board meeting

On 10 November 2025

05 Nov 2025, 04:40 pm

Nidan Laboratories & Healthcare to conduct board meeting

On 31 July 2025

29 Jul 2025, 11:27 am

Nidan Laboratories & Healthcare declare Quarterly Result

On 28 May 2025

23 May 2025, 12:49 pm

Nidan Laboratories & Healthcare Ltd Stock Analysis

Annual revenue for Nidan Laboratories & Healthcare Ltd decreased by 0.54% to ₹26.78 crore in FY 2025 from ₹26.92 crore in FY 2024.
Annual Net Profit for Nidan Laboratories & Healthcare Ltd decreased by 161.16% to ₹1.98 crore in FY 2025 from ₹-3.23 crore in FY 2024.
Promoter Shareholding in Nidan Laboratories & Healthcare Ltd remains unchanged by 0.00% in the most recent quarter, from 57.04% in March 2025 to 57.04% in September 2025.
Nidan Laboratories & Healthcare Ltd delivered a 1-year return of -30.17% compared to the Nifty 50, which provided a return of 10.91% as of the last trading session.
Nidan Laboratories & Healthcare Ltd share price moved down by 100.00% from its previous close of INR ₹20.25. The latest Nidan Laboratories & Healthcare Ltd share price is INR ₹0.
Nidan Laboratories & Healthcare Ltd share price today has been at a low of 19.35 and a high of 20. Over the past 52 weeks, the Nidan Laboratories & Healthcare Ltd share price has seen a low of 16.05 and a high of 31.60.